IP Library Granted Patent US 8,629,288
Granted Patent B2
US 8,629,288 · App. 12/919,365 · Granted Jan 14, 2014

Method for the regioselective synthesis of 1-alky1-3-haloalkyl-pyrazole-4-carboxylic acid derivatives

Inventors: Sergii Pazenok (Solingen, DE); Norbert Lui (Odenthal, DE); Jens-Dietmar Heinrich (Burscheid, DE); Thomas Wollner (Köln, DE)
Assignee: Bayer Intellectual Property GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,629,288
App. No.
12/919,365
Granted
Jan 14, 2014
Kind
B2
Abstract

The present invention relates to a process for the regioselective synthesis of 1-alkyl-3-halo-alkylpyrazole-4-carboxylic acid derivatives by cyclization of 2,3-disubstituted acrylic acid derivatives, and to the hydrazones formed as intermediates in the process.

Claims (44)

1. A process for preparing a 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivative of formula (I)

in which

R 1 is C 1-12 -alkyl, which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, —OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group and X′ is F, Cl, Br, or I;

R 2 is a C 1 -C 4 -alkyl group which is optionally substituted by one, two or three halogen atoms selected from the group consisting of F, Cl and Br or by a CF 3 group;

Y is (C═O)OR 3 , where R 3 is selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, C 2-12 -alkenyl, C 2-12 -alkynyl, C 6-8 -aryl, C 7-19 -aryl-alkyl and C 7-19 -alkylaryl, each of which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group and X′ is F, Cl, Br, or I;

comprising at least one of the reaction sequences consisting of steps (A) and (D), (B) and (D) or (C) and (D) below:

(A) reaction of a 2-acylated or 2-iminoalkylated acrylic acid derivative of formula (II),

in which

Z is selected from the group consisting of O, S and N + R 10 R 11 , where R 10 and R 11 independently of one another are selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, C 2-12 -alkenyl, C 2-12 -alkynyl, C 6-8 -aryl, C 7-19 -arylalkyl and C 7-19 -alkylaryl groups, each of which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, —OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group, X′ is F, Cl, Br, or I, and R 10 and R 11 together with the nitrogen atom to which they are attached optionally form a 5- or 6-membered ring which optionally contains one or two further heteroatoms selected from the group consisting of O, S and an SO 2 group and which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, —OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group, and X′ is F, Cl, Br, or I;

A is a leaving group NR 12 R 13 , where R 12 and R 13 independently of one another are selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, C 2-12 -alkenyl, C 2-12 -alkynyl, C 6-8 -aryl, C 7-19 -aryl-alkyl and C 7-19 -alkylaryl each of which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, —OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group, X′ is F, Cl, Br, or I, and R 12 and R 13 together with the nitrogen atom to which they are attached optionally form a 5- or 6-membered ring which optionally contains one or two further heteroatoms selected from the group consisting of O, S and an SO 2 group and which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, —OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group and X′ is F, Cl, Br, or I;

with an N-alkylhydrazone of formula (III)

in which

R 8 and R 9 independently of one another are selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, C 2-12 -alkenyl, C 2-12 -alkynyl, C 6-8 -aryl, C 7-19 -aryl alkyl and C 7-19 -alkylaryl, each of which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, —OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group, X′ is F, Cl, Br, or I, and R 8 and R 9 together with the carbon atom to which they are attached optionally form a 5- or 6-membered ring which optionally contains one or two further heteroatoms selected from the group consisting of O, S and an SO 2 group and which is optionally substituted by one or more groups selected from the group consisting of —R′, —X′, —OR′, —SR′, —NR′ 2 , —SiR′ 3 , —COOR′, —(C═O)R′, —CN and —CONR′ 2 , where R′ is hydrogen or a C 1-12 -alkyl group and X′ is F, Cl, Br, or I;

(B) acylation of an acrylic acid hydrazone of formula (VI);

with an acyl halide of formula (X), where X′ is selected from the group consisting of F, Cl, Br and I:

(C) iminoalkylation of an acrylic acid hydrazone of the formula (VI) above with an α,α-dihaloamine of formula (XI), where X′ is selected from the group consisting of F, Cl, Br and I:

(D) cyclization of an intermediate obtained in step (A), (B) or (C) to give the 3-haloalkylpyrazole-4-carboxylic acid derivative of the formula (I).

2. The process according to claim 1 , wherein the reaction sequence consists of steps (A) and (D).

3. The process according to claim 1 , wherein the reaction sequence consists of steps (B) and (D).

4. The process according to claim 1 , wherein the reaction sequence consists of steps (C) and (D).

5. The process according to claim 1 , wherein the acyl halide of the formula (X) in step (B) is selected from the group consisting of difluoroacetyl fluoride and difluoroacetyl chloride.

6. The process according to claim 1 , wherein the α,α-dihaloamine of the formula (XI) in step (C) is 1,1,2,2-tetrafluoroethyl-N,N-dimethylamine.

7. The process according to claim 1 , wherein the 2-acylated or 2-iminoalkylated acrylic acid derivative of the formula (II) is selected from the group consisting of N-1-(trifluoromethyl)-3-(dimethylamino)-2-(ethoxycarbonyl)prop-2-en-1-ylidene]-N-methyl-methanaminium chloride, N-1-(difluoromethyl)-3-(dimethylamino)-2-(ethoxy-carbonyl)prop-2-en-1-ylidene]-N-methylmethanaminium tetrafluoroborate and N-[3-(dimethylamino)-2-(ethoxycarbonyl)-1-(1,1,2,2-tetrafluoroethyl)prop-2-en-1-ylidene]-N-methylmethanaminium chloride.

8. The process according to claim 1 , wherein the N-alkylhydrazone of the formula (III) is selected from the group consisting of 1-methyl-2-(1-methylethylidene)hydrazine, 1-methyl-2-(1phenyl ethylidene)hydrazine, 1-methyl-2-(1,2,2-trimethylpropylidene)hydrazine, 1-methyl-2-(1-methylpropylidene)hydrazine, 1-cyclohexylidene-2-methylhydrazine, 1-methyl-2-(phenylmethylidene)hydrazine, 1-(diphenylmethyl-idene)-2-methylhydrazine, and ethyl 2-[(dimethylamino)methylidene]-4,4,4-tri-fluoro-3-oxobutanoate.

9. The process according to claim 1 , wherein the acrylic acid hydrazone of the formula (VI) in steps (B) and (C) is selected from the group consisting of ethyl (2E)-3-[1-methyl-2-(propan-2-ylidene)hydrazinyl]prop-2-enoate, ethyl (2Z)-3-[1-methyl-2-(propan-2-ylidene)hydrazinyl]prop-2-enoate, methyl 3-[1-methyl-2-(propan-2-ylidene)hydrazinyl]prop-2-enoate, propyl 3-[1-methyl-2-(propan-2-ylidene)hydrazinyl]prop-2-enoate, ethyl (2E)-3-[1-methyl-2-(3,3-dimethylbutan-2-ylidene)hydrazinyl]prop-2-enoate, methyl 3-[1-methyl-2-(3,3-dimethylbutan-2-ylidene)hydrazinyl]prop-2-enoate, methyl 3-[1-methyl-2-(phenylmethylidene)-hydrazinyl]prop-2-enoate, (2E)-3-[1-methyl-2-(phenylmethyl idene)hydrazinyl]-prop-2-enenitrile and methyl 3-[1-ethyl-2-(propan-2-ylidene)hydrazinyl]prop-2-enoate.

10. A process for preparing a 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivative of formula (I)

in which

R 1 is C 1-4 -alkyl;

R 2 is a C 1 -C 4 -alkyl group which is optionally substituted by one, two or three halogen atoms selected from the group consisting of F, Cl and Br or by a CF 3 group;

is (C═O)OR 3 , where R 3 is selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, C 6-8 -aryl, C 7-19 -arylalkyl and C 7-19 -alkylaryl groups; comprising;

(a) reaction of a 2-acylated or 2-iminoalkylated acrylic acid derivative of formula (II),

in which

Z is selected from the group consisting of O, S and N + R 10 R 11 , where R 10 and R 11 independently of one another are selected from the group consisting of C 1-12 -alkyl or R 10 and R 11 together with the nitrogen atom to which they are attached optionally form a 5- or 6-membered ring;

A is a leaving group NR 12 R 13 , where R 12 and R 13 independently of one another are selected from C 1-12 -alkyl, or R 12 and R 13 together with the nitrogen atom to which they are attached optionally form a 5- or 6-membered ring;

with an N-alkylhydrazone of formula (III)

in which

R 8 and R 9 independently of one another are selected from the group consisting of hydrogen, C 1-12 -alkyl, C 3-8 -cycloalkyl, C 6-18 -aryl, C 7-19 -arylalkyl and C 7-19 -alkylaryl groups, or R 8 and R 9 together with the carbon atom to which they are attached optionally form a 5- or 6-membered ring;

to form an intermediate; and

(b) cyclization of the intermediate obtained in step (a) to give the 3-haloalkylpyrazole-4-carboxylic acid derivative of the formula (I).

11. The process according to claim 10 , wherein:

R′ is methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, or tert-butyl;

R 8 is selected from the group consisting of hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, tert-butyl, phenyl, tolyl, and cyclohexyl;

R 9 is selected from the group consisting of hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, tert-butyl, phenyl, tolyl, and cyclohexyl,

wherein R 8 and R 9 , together with the C-atom to which they are bound, optionally form a 5- or 6-membered ring.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2019
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Reel/Frame 049359/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2015
From: BAYER CROPSCIENCE AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 035011/0799 →
DOCUMENT EVIDENCING ASSIGNMENT Recorded Sep 25, 2013
From: BAYER CROPSCIENCE AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 031282/0873 →
CORRECTIVE ASSIGNMENT TO CORRECT THE MISSPELLING OF THE INVENTORS NAME DR. NORBET LUI PREVIOUSLY RECORDED ON REEL 024977 FRAME 0527. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT SPELLING OF INVENTOR'S NAME IS DR. NORBERT LUI. Recorded Sep 24, 2010
From: PAZENOK, SERGII, DR.; LUI, NORBERT, DR.; HEINRICH, JENS-DIETMAR; WOLLNER, THOMAS
To: BAYER CROPSCIENCE AG
Reel/Frame 025036/0850 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2010
From: PAZENOK, SERGII, DR.; HEINRICH, JENS-DIETMAR; WOLLNER, THOMAS; LUI, NORBET, DR.
To: BAYER CROPSCIENCE AG
Reel/Frame 024977/0527 →
Priority Claims (1)
EP 08151891 · Feb 25, 2008 · regional
Continuity (1)
Related Publication 20110009642A1 · Jan 13, 2011